Arlene Amor

Dr. Arlene Amor currently serves as Director of Caerus Consulting, an Australia-based CRO. She is a recognized expert in Pharmacovigilance in Asia Pacific. Prior to joining Caerus, Dr. Amor was the Regional Head Asia-Pacific for Benefit Risk Management (BRM), division of Johnson & Johnson. Her role in the Asia-Pacific region was focused on the development and support of pharmacovigilance activities in J&J operating companies in Asia Pacific. Dr. Amor has also been involved as a speaker and adviser on many drug safety issues for various Regulatory Agencies within Asia Pacific. She has also been involved with a number of initiatives to promote and develop pharmacovigilance in the region.

Dr. Amor has over 19 years of experience in the pharmaceutical industry. She is trained as a physician in the Philippines. She started her career in Australia in 1990 with the Devices Branch of the Therapeutics Goods Administration (TGA: Australian health authority) where she worked for several years as a Technical Reviewer. She entered the pharmaceutical industry and held various senior management positions which included Director of Clinical Operations Asia-Pacific (Omnicare), Associate Medical Director/Safety Officer (Upjohn/Pharmacia) and as Medical Director (Solvay).